Abstract
GH secretion by the pituitary is the result of the balance between the stimulatory effect of GHRH and the inhibitory effect of SS. Patients with mutations in GHRH receptor (GHRH-R) gene (GHRH-R) offer a unique model to study the mechanism of action of different GH secretion stimuli. In the past, we have demonstrated a small but significant GH response to a GH secretagogue (GHRP-2) in a homogenous cohort of patients with severe GH deficiency (GHD) due to a homozygous null mutation in GHRH-R (IVS1+1G→A). Now, we sought to determine if we could detect a GH response to hypoglycemia (ITT: insulin tolerance test) or clonidine (CL) in these patients. Nine young GHD subjects underwent both ITT and CL tests, and 2 additional subjects underwent only CL test. There was a small but significant GH increase during ITT, but not during CL test. These results indicate that a minimal albeit significant GH response to ITT can occur despite complete lack of GHRH-R function.
Similar content being viewed by others
References
Veldhuis JD, Bowers CY. Human GH pulsatility: an ensemble property regulated by age and gender. J Endocrinol Invest 2003, 26: 799–813.
Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998, 19: 717–97.
Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004, 101: 8227–32.
Cordido F, Dieguez C, Casanueva FA. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab 1990, 70: 1361–70.
Murray RA, Maheshwari HG, Russell EJ, Baumann G. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. AJNR Am J Neuradiol 2000, 21: 685–9.
Oliveira HA, Salvatori R, Krauss MP, Oliveira CR, Silva PR, Aguiar-Oliveira MH. Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene. Eur J Endocrinol 2003, 148: 427–32.
Roelfsema F, Biermasz NR, Veldman RG, et al. Growth hormone secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 2001, 86: 2459–64.
Maheshwari HG, Pezzoli SS, Rahim A, Shalet SM, Thorner MO, Baumann G. Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. Am J Physiol Endocrinol Metab 2002, 282: E943–51.
Gondo RG, Aguiar-Oliveira MH, Hayashida CY, et al. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J Clin Endocrinol Metab 2001, 86: 3279–83.
Salvatori R, Hayashida CY, Aguiar-Oliveira MH, et al. Familial dwarfism due to a novel mutation of the growth hormonereleasing hormone receptor gene. J Clin Endocrinol Metab 1999, 84: 917–23.
Aguiar-Oliveira MH, Gill MS, Barreto ESA, et al. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab 1999, 84: 4118–26.
Hayashida CY, Gondo RG, Ferrari C, et al. Familial growth hormone deficiency with mutated GHRH receptor gene: clinical and hormonal findings in homozygous and heterozygous individuals from Itabaianinha-SE. Eur J Endocrinol 2000, 142: 557–63.
Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford: Clarendon. 1994, 146–67.
Strasburger CJ. Laboratory assessment of GH. Growth Horm IGF Res 1998, 8(Suppl A): 41–6.
Mullis PE. Genetic control of growth. Eur J Endocrinol 2005, 152: 11–31.
Alba M, Salvatori R. GHRH receptor mutations in isolated GH deficiency. The Endocrinologist 2003, 13: 422–7.
Maheshwari HG, Silverman BL, Dupuis J, Baumann G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. J Clin Endocrinol Metab 1998, 83: 4065–74.
Salvatori R, Fan X, Veldhuis JD, Couch R. Serum GH response to pharmacological stimuli and physical exercise in two new inactivating mutations in the GH-releasing hormone. Eur J Endocrinol 2002, 147: 591–6.
Frishmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999, 8: 1893–900.
Fisher BM, Thornton S, Hepburn DA, et al. Effect of alphaadrenergic blockade on pituitary hormonal responses to insulin-induced hypoglycemia in humans. Acta Endocrinol (Copenh) 1991, 125: 372–7.
Darzy KH, Aimaretti G, Wieringa, Gattamaneni HR, Ghigo Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 2003, 88: 95–102.
Masuda A, Shibasaki T, Hotta M, et al. Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man. Regul Pept 1990, 31: 53–64.
Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects. J Clin Endocrinol Metab 1996, 81: 1952–5.
Gil-Ad I, Gurewitz R, Marcovici O, Rosenfeld J, Laron Z. Effect of aging on human plasma growth hormone response to clonidine. Mech Aging Dev 1984 27: 97–100.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salvatori, R., Serpa, M.G., Parmigiani, G. et al. GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome. J Endocrinol Invest 29, 805–808 (2006). https://doi.org/10.1007/BF03347374
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347374